Renal denervation: one step backwards, three steps forward

Markus P. Schlaich, George L. Bakris

Research output: Contribution to journalEditorial

2 Citations (Scopus)

Abstract

Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.

Original languageEnglish
Pages (from-to)602-604
Number of pages2
JournalNature Reviews Nephrology
Volume14
Issue number10
DOIs
Publication statusPublished - Oct 2018

    Fingerprint

Cite this